News

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...
Wegovy and Mounjaro have been taking the world by storm for their unprecedented ability to help people shed weight. New ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...
Larger bodies gained visibility in recent years. One writer explores the limitations that are now running rampant within the fashion industry regarding plus-size brands and figures.
In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
(Reuters) -The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as ...
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...